GCC · UAE · Distribution intelligence
Pharma Distribution Intelligence — UAE
Distrolens maps every MOHAP-licensed pharma distributor in the United Arab Emirates: who they represent, how recently their licenses were renewed, and how to reach commercial decision-makers — all from public registries and primary sources.
Market context
Why UAE matters
The UAE pharmaceutical distribution market intermediates $4B+ in annual flow. Greater than 90% of imported brands route through 12 anchor distributors based in Dubai and Abu Dhabi free zones, with a long tail of specialist channels.
Primary regulator: Ministry of Health and Prevention (MOHAP) — www.mohap.gov.ae
What we map
Public-source signals for UAE
- MOHAP wholesale + manufacturing license holders
- Brand-to-distributor authorization chains (manufacturer → UAE importer)
- Free-zone presence: JAFZA, DAFZA, Sharjah Healthcare City, Dubai Healthcare City
- Ownership / subsidiary edges from Wikidata + EDGAR Ex21 + corporate registries
- Decision-maker contacts (commercial, regulatory, supply chain)
- Tender awards from MOHAP and Emirates Health Services
Use cases
How brand owners use UAE data
Brand owner entering the UAE
You hold a manufacturing dossier and need a distributor with MOHAP relationships, free-zone storage, and a comparable therapeutic portfolio. We deliver a shortlist with portfolio overlap, license freshness, and warm-intro paths in days.
Diligence on an existing UAE distributor
Before a contract renewal — who else do they represent? Are their MOHAP licenses current? Have they been named in any sanctions or compliance signals? We deliver a one-page evidence-backed snapshot.
Tender intelligence
MOHAP and EHS tender awards mapped over time. Spot which distributors are winning what — and where the white space is.
Founder-led · Brief-form intake
Request a UAE brief
Send your therapeutic class, target launch window, and any constraints. We respond within 1 business day with scope, evidence sample, and timeline.
Start brief →